Enterin Inc. Raises $12.7 Million in Series A Financing

PHILADELPHIA, July 15, 2017 /PRNewswire/ -- Enterin Inc., a Philadelphia-based biotechnology company developing novel compounds to treat Parkinson's disease (PD), today announced the completion of a $12.7 million Series A financing round. The financing included new investors New Ventures...